BAFNA PHARMACEUTICALS
Back to Cashflow Statement
|
BAFNA PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹22 Cr | ₹9.48 Cr | ₹4.95 Cr | ₹9.73 Cr | ₹-14 Cr |
What is the latest Cash Flow from Operating Activities ratio of BAFNA PHARMACEUTICALS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹22 Cr |
| Mar2024 | ₹9.48 Cr |
| Mar2023 | ₹4.95 Cr |
| Mar2022 | ₹9.73 Cr |
| Mar2021 | ₹-14 Cr |
How is Cash Flow from Operating Activities of BAFNA PHARMACEUTICALS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹22 Cr | 133.38 | |
| Mar2024 | ₹9.48 Cr | 91.50 | |
| Mar2023 | ₹4.95 Cr | -49.09 | |
| Mar2022 | ₹9.73 Cr | Positive | |
| Mar2021 | ₹-14 Cr | - | |
Compare Cash Flow from Operating Activities of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹315.2 Cr | -14% | -7.3% | 70.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹416,728.0 Cr | -1.3% | -3.9% | -5.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,248.0 Cr | -2.3% | 0.9% | 12.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,627.0 Cr | 0.3% | 3.9% | 19.2% | Stock Analytics | |
| CIPLA | ₹118,423.0 Cr | -4.2% | -3.1% | -1.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,462.0 Cr | -3.2% | -4.5% | -11.8% | Stock Analytics | |
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAFNA PHARMACEUTICALS | -14% |
-7.3% |
70.7% |
| SENSEX | -1.8% |
-0.6% |
7.3% |
You may also like the below Video Courses